查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1855937

2025年全球眼科基因诊断市场报告

Ocular Genetic Diagnostic Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，眼科基因检测市场呈现强劲成长势头，预计将从2024年的9.8亿美元成长到2025年的10.7亿美元，复合年增长率达9.7%。预测期内的成长主要归功于分子诊断技术的早期应用、人们对遗传性眼科疾病的认识不断提高、学术和临床研究的拓展、视网膜营养不良盛行率的上升以及对儿童基因检测需求的增长。

预计未来几年，眼科基因诊断市场将维持强劲成长，2029年市场规模将达到15.3亿美元，复合年增长率（CAGR）为9.4%。预测期内的成长主要受以下因素驱动：对个人化眼科护理的需求不断增长、面向消费者的基因检测服务日益普及、基因治疗试验投资不断增加、精准医疗倡议蓬勃发展以及人工智能在基因数据解读中的应用。预测期内的关键趋势包括：基于人工智慧的基因分析应用日益广泛、家用基因检测套组的普及、产前眼科基因筛检需求不断增长、基因特异性诊断平台的开发以及云端基础基因数据储存技术的进步。

眼科遗传诊断是一门专注于检测和分析与眼部健康和视力相关的基因变异的专业。它涉及对与眼科疾病相关的遗传因素进行系统性检测，目的是确定眼科疾病的遗传基础。

眼科遗传诊断的主要检测类型包括单基因检测、基因组检测、全外EXOME定序和全基因组定序。单基因检测（也称为单例检测）一次评估一个特定基因，适用于临床特征和家族病史强烈提示基因突变的情况。相关技术包括定序、聚合酵素链锁反应(PCR)、微阵列技术和新一代定序 (NGS)。应用领域包括视网膜疾病、白内障诊断、遗传性眼科疾病和老龄化黄斑部病变，最终用户包括医院、诊断实验室、学术机构和研究机构。

美国在2025年春季突然提高关税，由此引发的贸易摩擦对医疗保健产业造成了严重衝击，尤其对关键医疗设备、诊断试剂和药品的供应造成了严重影响。医院和医疗机构面临进口手术器械、影像设备以及注射器、导管等耗材成本不断上涨的困境。这些成本的增加加剧了医疗预算的紧张，导致一些医疗机构必须推迟设备升级或将成本转嫁给患者。此外，原料和零件的关税也阻碍了必需药品和医疗设备的生产，造成供应链瓶颈。为了应对这项挑战，医疗产业正在积极调整筹资策略，尽可能地促进本地生产，并呼吁对紧急医疗产品实施关税豁免。

本研究报告是商业研究公司（The Business Research Company）全新系列报告的一部分，提供眼科基因诊断市场统计数据，例如全球眼科基因诊断市场规模、区域份额、竞争对手及其市场份额、详细的眼科基因诊断市场细分、市场趋势和商机，以及您在眼科基因诊断行业取得成功所需的数据。这张眼科基因诊断市场研究报告对行业现状和未来发展趋势进行了详细分析，为您提供所需的一切资讯。

眼科疾病的日益普遍推动了眼科基因诊断市场的扩张。眼科疾病涵盖多种影响眼睛结构和功能的疾病，若不及时治疗，可能导致视力丧失甚至失明。眼部疾病的增加主要是因为长时间使用电子萤幕和电子设备，导致眼睛疲劳、干眼症和其他视力障碍。眼科基因诊断透过早期识别遗传因素、更好地了解疾病起源以及提高诊断准确性和优化患者护理策略，为这些疾病的治疗提供支持。例如，美国盲人基金会（总部位于美国的视障人士支援组织）于2025年2月进行的一项调查发现，5,190万18岁及以上的美国成年人报告存在某种形式的视觉障碍者障碍。其中，370万人即使戴眼镜也视力模糊，30.7万人完全失明。其余4,790万人即使配戴矫正眼镜也存在轻度视力障碍。视力障碍病例的增加导致眼科保健领域对基因诊断的需求不断增长。

该市场中的企业正优先发展专业临床服务，以改善遗传性眼科疾病患者提供集中护理，将基因检测、咨询和个人化治疗方案整合于同一环境中。此举有助于更及时、更准确地识别遗传性眼科疾病，并根据每位患者独特的基因谱提供量身定制的治疗。此类临床服务反映了眼部遗传学领域向精准医疗和以患者为中心的综合护理模式发展的更广泛趋势。

2024年10月，专注于眼科治疗的美国生物製药公司Ocufire收购了Opus Genetics，收购金额未揭露。此次收购使Ocufire得以拓展其开发平臺，纳入针对罕见遗传性眼科疾病的基因治疗计画。该公司旨在透过整合其现有的先进药物组合和早期基因疗法，满足视网膜退化性疾病领域尚未满足的医疗需求。 Opus Genetics同样位于美国，专注于开发治疗遗传性视网膜疾病（导致进行性视力丧失）的治疗方法。

眼科基因诊断市场由提供分子诊断服务、基因咨询服务、风险评估服务和客製化基因报告服务等服务的营业单位所获得的收入组成。市场价值还包括服务提供者销售的或包含在其服务产品中的任何相关产品的价值。眼科基因诊断市场还包括基因检测套组、检测试剂和耗材的销售额。该市场的价值为“出厂价”，即製造商或生产商销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接销售给最终客户的商品价值。该市场中的商品价值还包括製造商提供的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税，以及新冠疫情及其復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球眼科基因诊断：PESTEL 分析（政治、社会、科技、环境、法律因素、驱动因素与限制因素）
  • 终端用户产业分析
  • 全球眼科基因诊断市场：成长率分析
  • 全球眼科基因诊断市场表现：规模与成长，2019-2024年
  • 全球眼科基因诊断市场预测：规模与成长，2024-2029年，2034年预测
  • 全球眼科基因诊断：潜在市场规模 (TAM)

第六章 市场细分

  • 全球眼科基因诊断市场依检测类型、表现及预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 单基因检测
  • 小组测试
  • 全EXOME定序
  • 全基因组定序
  • 全球眼科基因诊断市场：依技术类型、表现及预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 定序技术
  • 聚合酵素链锁反应（PCR）
  • 微阵列技术
  • 次世代定序仪（NGS）
  • 全球眼科基因诊断市场：依应用、效能和预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 视网膜疾病
  • 白内障诊断
  • 遗传性眼科疾病
  • 老龄化黄斑部病变
  • 全球眼科基因诊断市场：依最终使用者、效能和预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 医院
  • 诊断实验室
  • 学术研究机构
  • 其他最终用户
  • 全球眼科基因诊断市场：依单一基因检测、类型、表现及预测细分，2019-2024年、2024-2029年预测、2034年预测
  • 视网膜母细胞瘤基因检测（RB1）
  • RPE65基因突变检测
  • MYOC基因检测（青光眼）
  • OPA1基因检测（视神经萎缩）
  • BEST1基因检测（最佳疾病）
  • 全球眼科基因诊断市场：依检测项目、类型、表现及预测细分，2019-2024年、2024-2029年预测、2034年预测
  • 遗传性视网膜疾病 (IRD) 小组
  • 青光眼基因检测
  • 黄斑部营养不良症小组
  • 视神经疾病专家小组
  • 症状眼科疾病检测组
  • 全球眼科基因诊断市场：按全EXOME定序 (WES)、类型、表现和预测进行细分，2019-2024 年、2024-2029 年预测、2034 年预测
  • 三重EXOME定序
  • 诊断性EXOME定序
  • EXOME再分析服务
  • 快速EXOME检测
  • 产前外EXOME定序
  • 全球眼科基因诊断市场：按全基因组定序 (WGS)、类型、表现和预测进行细分，2019-2024 年、2024-2029 年预测、2034 年预测
  • 临床全基因组定序
  • 快速全基因组定序
  • 儿童基因组定序
  • 产前全基因组定序
  • 罕见眼科疾病的基因组定序

第七章 区域和国家分析

  • 全球眼科基因诊断市场：依地区、绩效及预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 全球眼科基因诊断市场：依国家、绩效及预测划分，2019-2024 年、2024-2029 年预测、2034 年预测

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第十八章：法国市场

第十九章：义大利市场

第二十章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第三十章：竞争格局与公司概况

  • 眼科基因诊断市场：竞争格局
  • 眼科基因诊断市场：公司概况
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Quest Diagnostics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
    • The Children's Hospital of Philadelphia Overview, Products and Services, Strategy and Financial Analysis
    • University of Iowa Hospitals and Clinics Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • PerkinElmer Inc.
  • Natera Inc.
  • Myriad Genetics Inc.
  • Fulgent Genetics Inc.
  • ARUP Laboratories Inc.
  • Invitae Corporation
  • Spark Therapeutics Inc.
  • GeneDx LLC
  • Blueprint Genetics Oy
  • Medgenome Labs Inc.
  • Centogene NV
  • PreventionGenetics LLC
  • Molecular Vision Laboratory LLC
  • Casey Eye Institute
  • Moorfields Eye Hospital & UCL Institute of Ophthalmology

第32章 全球市场竞争基准化分析与仪錶板

第33章 重大併购

第34章 近期市场趋势

第35章：高潜力市场国家、细分市场与策略

  • 2029年眼科基因诊断市场：蕴藏新机会的国家
  • 2029年眼科基因诊断市场：新兴细分市场机会
  • 2029年眼科基因诊断市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章附录

简介目录
Product Code: r38589

Ocular genetic diagnostics refers to the specialized field focused on detecting and analyzing inherited genetic variations linked to eye health and vision. It involves the systematic examination of genetic factors that contribute to ocular conditions, with the goal of identifying the hereditary basis of these disorders.

The primary test types in ocular genetic diagnostics include single gene testing, panel testing, whole exome sequencing, and whole genome sequencing. Single gene testing, also called singleton testing, evaluates one specific gene at a time, typically when a mutation is strongly suspected based on clinical features or family history. Technology types include sequencing technology, polymerase chain reaction (PCR), microarray technology, and next-generation sequencing (NGS). Applications include retinal disorders, cataract diagnosis, inherited ocular diseases, and age-related macular degeneration, with end users such as hospitals, diagnostic laboratories, academic institutions, research institutes, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The ocular genetic diagnostic market research report is one of a series of new reports from The Business Research Company that provides ocular genetic diagnostic market statistics, including ocular genetic diagnostic industry global market size, regional shares, competitors with a ocular genetic diagnostic market share, detailed ocular genetic diagnostic market segments, market trends and opportunities, and any further data you may need to thrive in the ocular genetic diagnostic industry. The ocular genetic diagnostic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The ocular genetic diagnostics market size has grown strongly in recent years. It will grow from $0.98 billion in 2024 to $1.07 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. The growth during the historic period is attributed to the early adoption of molecular diagnostic techniques, rising awareness of inherited eye disorders, expansion of academic and clinical research, increasing incidence of retinal dystrophies, and growing demand for pediatric genetic testing.

The ocular genetic diagnostics market size is expected to see strong growth in the next few years. It will grow to $1.53 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. The growth during the forecast period is driven by rising demand for personalized ophthalmic care, expansion of direct-to-consumer genetic testing, increasing investments in gene therapy trials, growth of precision medicine initiatives, and the integration of artificial intelligence in genetic data interpretation. Key trends in the forecast period include greater use of artificial intelligence-powered genetic analysis, expansion of at-home genetic testing kits, rising demand for prenatal ocular genetic screening, development of gene-specific diagnostic platforms, and advancements in cloud-based genetic data storage.

The growing prevalence of eye diseases is contributing to the expansion of the ocular genetic diagnostic market. Eye diseases include a range of medical conditions that affect the eye's structure or function and can lead to vision loss or blindness if not properly treated. This increase in eye-related conditions is primarily driven by extended use of digital screens and electronic devices, which results in eye strain, dry eye, and other visual impairments. Ocular genetic diagnostics support the management of these conditions by identifying inherited genetic components early, providing a better understanding of disease origins, and improving diagnostic accuracy and patient care strategies. For example, in February 2025, a survey conducted by the American Foundation for the Blind, a United States-based organization supporting individuals with vision impairment, found that 51.9 million American adults aged 18 and older reported some degree of vision difficulty. Among them, 3.7 million have significant trouble seeing even while wearing glasses, and 307,000 are completely blind. The remaining 47.9 million experience mild visual difficulties despite using corrective lenses. This rise in vision problems is contributing to the growing demand for genetic diagnostics in ocular healthcare.

Companies involved in this market are prioritizing the development of specialized clinical services to improve early detection, diagnosis, and personalized treatment of hereditary eye conditions. Clinical services involve the professional evaluation, diagnosis, and management of patient health concerns. For instance, in October 2024, the Singapore National Eye Centre, a public-sector specialty eye hospital in Singapore, introduced the Ocular Genetics Service. This dedicated clinical program provides focused care for patients with inherited eye conditions, integrating genetic testing, counseling, and individualized treatment planning in one setting. The initiative allows for more timely and accurate identification of genetic eye disorders while offering care that aligns with the patient's unique genetic profile. This type of clinical service reflects a broader movement toward precision medicine and integrated, patient-centered care in the ocular genetics field.

In October 2024, Ocuphire Pharma Inc., a biopharmaceutical company based in the United States that specializes in ophthalmic treatments, acquired Opus Genetics Inc. for an undisclosed amount. This acquisition enables Ocuphire to broaden its research and development pipeline by incorporating gene therapy programs designed for rare genetic eye conditions. By combining its existing advanced-stage drug portfolio with early-stage genetic therapies, the company aims to address unmet needs in retinal degenerative diseases. Opus Genetics Inc., also based in the United States, focuses on the development of therapies for inherited retinal diseases associated with genes that cause progressive vision loss.

Major players in the ocular genetic diagnostic market are Thermo Fisher Scientific Inc., Quest Diagnostics Inc., Illumina Inc., The Children's Hospital of Philadelphia, University of Iowa Hospitals and Clinics, PerkinElmer Inc., Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., ARUP Laboratories Inc., Invitae Corporation, Spark Therapeutics Inc., GeneDx LLC, Blueprint Genetics Oy, Medgenome Labs Inc., Centogene NV, PreventionGenetics LLC, Molecular Vision Laboratory LLC, Casey Eye Institute, and Moorfields Eye Hospital & UCL Institute of Ophthalmology.

North America was the largest region in the ocular genetic diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in ocular genetic diagnostic report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the ocular genetic diagnostic market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The ocular genetic diagnostic market consists of revenues earned by entities by providing services such as molecular diagnostic services, genetic counseling services, risk assessment services, and customized genetic report services. The market value includes the value of related goods sold by the service provider or included within the service offering. The ocular genetic diagnostic market also includes sales of genetic testing kits, laboratory reagents, and consumables. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Ocular Genetic Diagnostic Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ocular genetic diagnostic market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ocular genetic diagnostic ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ocular genetic diagnostic market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Test Type: Single Gene Testing; Panel Testing; Whole Exome Sequencing; Whole Genome Sequencing
  • 2) By Technology Type: Sequencing Technology; Polymerase Chain Reaction (PCR); Microarray Technology; Next-Generation Sequencing (NGS)
  • 3) By Application: Retinal Disorders; Cataract Diagnosis; Inherited Ocular Disorders; Age-Related Macular Degeneration
  • 4) By End User: Hospitals; Diagnostic Laboratories; Academic And Research Institutes; Other End Users
  • Subsegments:
  • 1) By Single Gene Testing: Retinoblastoma Gene Testing (RB1); RPE65 Gene Mutation Testing; MYOC Gene Testing (Glaucoma); OPA1 Gene Testing (Optic Atrophy); BEST1 Gene Testing (Best Disease)
  • 2) By Panel Testing: Inherited Retinal Disease (IRD) Panels; Glaucoma Genetic Panels; Macular Dystrophy Panels; Optic Neuropathy Panels; Syndromic Ocular Disorder Panels
  • 3) By Whole Exome Sequencing (WES): Trio Exome Sequencing; Diagnostic Exome Sequencing; Exome Reanalysis Services; Rapid Exome Testing; Prenatal Exome Sequencing
  • 4) By Whole Genome Sequencing (WGS): Clinical Whole Genome Sequencing; Rapid Whole Genome Sequencing; Pediatric Genome Sequencing; Prenatal Whole Genome Sequencing; Ultra-Rare Eye Disease Genome Sequencing
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Quest Diagnostics Inc.; Illumina Inc.; The Children's Hospital of Philadelphia; University of Iowa Hospitals and Clinics; PerkinElmer Inc.; Natera Inc.; Myriad Genetics Inc.; Fulgent Genetics Inc.; ARUP Laboratories Inc.; Invitae Corporation; Spark Therapeutics Inc.; GeneDx LLC; Blueprint Genetics Oy; Medgenome Labs Inc.; Centogene NV; PreventionGenetics LLC; Molecular Vision Laboratory LLC; Casey Eye Institute; Moorfields Eye Hospital & UCL Institute of Ophthalmology.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Ocular Genetic Diagnostic Market Characteristics

3. Ocular Genetic Diagnostic Market Trends And Strategies

4. Ocular Genetic Diagnostic Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Ocular Genetic Diagnostic Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Ocular Genetic Diagnostic PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Ocular Genetic Diagnostic Market Growth Rate Analysis
  • 5.4. Global Ocular Genetic Diagnostic Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Ocular Genetic Diagnostic Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Ocular Genetic Diagnostic Total Addressable Market (TAM)

6. Ocular Genetic Diagnostic Market Segmentation

  • 6.1. Global Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single Gene Testing
  • Panel Testing
  • Whole Exome Sequencing
  • Whole Genome Sequencing
  • 6.2. Global Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sequencing Technology
  • Polymerase Chain Reaction (PCR)
  • Microarray Technology
  • Next-Generation Sequencing (NGS)
  • 6.3. Global Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Retinal Disorders
  • Cataract Diagnosis
  • Inherited Ocular Disorders
  • Age-Related Macular Degeneration
  • 6.4. Global Ocular Genetic Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Diagnostic Laboratories
  • Academic And Research Institutes
  • Other End Users
  • 6.5. Global Ocular Genetic Diagnostic Market, Sub-Segmentation Of Single Gene Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Retinoblastoma Gene Testing (RB1)
  • RPE65 Gene Mutation Testing
  • MYOC Gene Testing (Glaucoma)
  • OPA1 Gene Testing (Optic Atrophy)
  • BEST1 Gene Testing (Best Disease)
  • 6.6. Global Ocular Genetic Diagnostic Market, Sub-Segmentation Of Panel Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Inherited Retinal Disease (IRD) Panels
  • Glaucoma Genetic Panels
  • Macular Dystrophy Panels
  • Optic Neuropathy Panels
  • Syndromic Ocular Disorder Panels
  • 6.7. Global Ocular Genetic Diagnostic Market, Sub-Segmentation Of Whole Exome Sequencing (WES), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Trio Exome Sequencing
  • Diagnostic Exome Sequencing
  • Exome Reanalysis Services
  • Rapid Exome Testing
  • Prenatal Exome Sequencing
  • 6.8. Global Ocular Genetic Diagnostic Market, Sub-Segmentation Of Whole Genome Sequencing (WGS), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Clinical Whole Genome Sequencing
  • Rapid Whole Genome Sequencing
  • Pediatric Genome Sequencing
  • Prenatal Whole Genome Sequencing
  • Ultra-Rare Eye Disease Genome Sequencing

7. Ocular Genetic Diagnostic Market Regional And Country Analysis

  • 7.1. Global Ocular Genetic Diagnostic Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Ocular Genetic Diagnostic Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Ocular Genetic Diagnostic Market

  • 8.1. Asia-Pacific Ocular Genetic Diagnostic Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Ocular Genetic Diagnostic Market

  • 9.1. China Ocular Genetic Diagnostic Market Overview
  • 9.2. China Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Ocular Genetic Diagnostic Market

  • 10.1. India Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Ocular Genetic Diagnostic Market

  • 11.1. Japan Ocular Genetic Diagnostic Market Overview
  • 11.2. Japan Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Ocular Genetic Diagnostic Market

  • 12.1. Australia Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Ocular Genetic Diagnostic Market

  • 13.1. Indonesia Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Ocular Genetic Diagnostic Market

  • 14.1. South Korea Ocular Genetic Diagnostic Market Overview
  • 14.2. South Korea Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Ocular Genetic Diagnostic Market

  • 15.1. Western Europe Ocular Genetic Diagnostic Market Overview
  • 15.2. Western Europe Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Ocular Genetic Diagnostic Market

  • 16.1. UK Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Ocular Genetic Diagnostic Market

  • 17.1. Germany Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Ocular Genetic Diagnostic Market

  • 18.1. France Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Ocular Genetic Diagnostic Market

  • 19.1. Italy Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Ocular Genetic Diagnostic Market

  • 20.1. Spain Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Ocular Genetic Diagnostic Market

  • 21.1. Eastern Europe Ocular Genetic Diagnostic Market Overview
  • 21.2. Eastern Europe Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Ocular Genetic Diagnostic Market

  • 22.1. Russia Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Ocular Genetic Diagnostic Market

  • 23.1. North America Ocular Genetic Diagnostic Market Overview
  • 23.2. North America Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Ocular Genetic Diagnostic Market

  • 24.1. USA Ocular Genetic Diagnostic Market Overview
  • 24.2. USA Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Ocular Genetic Diagnostic Market

  • 25.1. Canada Ocular Genetic Diagnostic Market Overview
  • 25.2. Canada Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Ocular Genetic Diagnostic Market

  • 26.1. South America Ocular Genetic Diagnostic Market Overview
  • 26.2. South America Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Ocular Genetic Diagnostic Market

  • 27.1. Brazil Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Ocular Genetic Diagnostic Market

  • 28.1. Middle East Ocular Genetic Diagnostic Market Overview
  • 28.2. Middle East Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Ocular Genetic Diagnostic Market

  • 29.1. Africa Ocular Genetic Diagnostic Market Overview
  • 29.2. Africa Ocular Genetic Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Ocular Genetic Diagnostic Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Ocular Genetic Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Ocular Genetic Diagnostic Market Competitive Landscape And Company Profiles

  • 30.1. Ocular Genetic Diagnostic Market Competitive Landscape
  • 30.2. Ocular Genetic Diagnostic Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Quest Diagnostics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. The Children's Hospital of Philadelphia Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. University of Iowa Hospitals and Clinics Overview, Products and Services, Strategy and Financial Analysis

31. Ocular Genetic Diagnostic Market Other Major And Innovative Companies

  • 31.1. PerkinElmer Inc.
  • 31.2. Natera Inc.
  • 31.3. Myriad Genetics Inc.
  • 31.4. Fulgent Genetics Inc.
  • 31.5. ARUP Laboratories Inc.
  • 31.6. Invitae Corporation
  • 31.7. Spark Therapeutics Inc.
  • 31.8. GeneDx LLC
  • 31.9. Blueprint Genetics Oy
  • 31.10. Medgenome Labs Inc.
  • 31.11. Centogene NV
  • 31.12. PreventionGenetics LLC
  • 31.13. Molecular Vision Laboratory LLC
  • 31.14. Casey Eye Institute
  • 31.15. Moorfields Eye Hospital & UCL Institute of Ophthalmology

32. Global Ocular Genetic Diagnostic Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Ocular Genetic Diagnostic Market

34. Recent Developments In The Ocular Genetic Diagnostic Market

35. Ocular Genetic Diagnostic Market High Potential Countries, Segments and Strategies

  • 35.1 Ocular Genetic Diagnostic Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Ocular Genetic Diagnostic Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Ocular Genetic Diagnostic Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer